NASDAQ : NXL
Nexalin Technology, Inc. — Financial statements
Healthcare · Medical Devices · United States
Last price 1.6 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.33M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Nexalin Technology, Inc. (NXL) reported revenue of 217.16K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 217.16K | 301.65K | 168.72K | 110.75K | 1.32M | 144.06K |
| Cost of Revenue | 30.06K | 61.37K | 36.59K | 25.69K | 363.21K | 21.44K |
| Gross Profit | 187.10K | 240.27K | 132.13K | 85.06K | 958.14K | 122.62K |
| Selling, General & Admin | 7.95M | 7.55M | 6.70M | 3.86M | 2.79M | 6.14M |
| Research & Development | 1.36M | 1.08M | 1.19M | 1.92M | ||
| Operating Expenses | 9.31M | 8.63M | 7.89M | 5.78M | 2.79M | 6.14M |
| Operating Income | -9.13M | -8.39M | -7.75M | -5.70M | -1.83M | -6.02M |
| Interest Expense | -38.84K | -59.38K | -82.32K | |||
| Interest & Investment Income | 2.61K | 8.24K | 3.19K | |||
| Earnings From Equity Investments | -1.05K | 4.85K | ||||
| Other Non Operating Income (Expenses) | 31.12K | 34.57K | 9.31K | 239.54K | 171.68K | |
| EBT Excluding Unusual Items | -9.09M | -8.35M | -7.74M | -5.50M | -1.72M | -6.10M |
| Gain (Loss) on Sale of Investments | 103.42K | 126.94K | 130.11K | 231.88K | ||
| Other Unusual Items | 615.00K | 22.92K | 22.92K | |||
| Pretax Income | -8.99M | -8.22M | -7.61M | -4.65M | -1.70M | -6.08M |
| Net Income | -8.99M | -8.22M | -7.61M | -4.65M | -1.70M | -6.08M |
| Net Income to Common | -8.99M | -8.22M | -7.61M | -4.65M | -1.70M | -6.08M |
| Shares Outstanding (Basic) | 645.74K | 546.41K | 307.19K | 245.23K | 185.75K | 141.88K |
| Shares Outstanding (Diluted) | 645.74K | 546.41K | 307.19K | 245.23K | 185.75K | 141.88K |
| EPS (Basic) | -13.92 | -15.05 | -24.76 | -18.96 | -9.14 | -42.84 |
| EPS (Diluted) | -13.92 | -15.05 | -24.76 | -18.96 | -9.14 | -42.84 |
| Free Cash Flow | -6.18M | -4.96M | -3.94M | -3.84M | -2.22M | -1.08M |
| Free Cash Flow Per Share | -9.57 | -9.07 | -12.84 | -15.64 | -11.93 | -7.59 |
| Gross Margin | 86.16% | 79.65% | 78.31% | 76.81% | 72.51% | 85.12% |
| Operating Margin | -4,202.53% | -2,781.69% | -4,596.14% | -5,143.48% | -138.72% | -4,177.70% |
| Profit Margin | -4,139.38% | -2,725.76% | -4,508.73% | -4,197.56% | -128.49% | -4,218.93% |
| Free Cash Flow Margin | -2,845.05% | -1,643.53% | -2,337.82% | -3,463.16% | -167.68% | -747.43% |
| EBITDA | -9.08M | -8.37M | -7.74M | -5.69M | -1.83M | -6.02M |
| EBITDA Margin | -138.68% | |||||
| D&A For EBITDA | 45.53K | 21.54K | 15.11K | 4.25K | 535.00 | 537.00 |
| EBIT | -9.13M | -8.39M | -7.75M | -5.70M | -1.83M | -6.02M |
| EBIT Margin | -138.72% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.00M | 654.78K | 574.49K | 580.23K | 162.74K | 661.78K |
| Short-Term Investments | 3.07M | 2.91M | 2.37M | 6.83M | ||
| Cash & Short-Term Investments | 1.00M | 3.72M | 3.48M | 2.95M | 6.99M | 661.78K |
| Receivables | 133.93K | 81.57K | 13.04K | 9.37K | 4.88K | 16.30K |
| Inventory | 292.68K | 131.47K | 174.58K | 156.42K | 154.37K | 31.41K |
| Prepaid Expenses | 174.49K | 363.01K | 293.60K | 315.67K | 272.28K | 43.17K |
| Total Current Assets | 1.86M | 4.30M | 3.96M | 3.43M | 7.43M | 752.66K |
| Property, Plant & Equipment | 42.43K | 496.00 | 6.67K | 1.04K | ||
| Long-Term Investments | 864.00 | 96.00K | ||||
| Other Intangible Assets | 1.10M | 336.05K | 260.73K | 105.53K | ||
| Total Assets | 3.00M | 4.64M | 4.22M | 3.63M | 7.43M | 753.70K |
| Accounts Payable | 239.45K | 244.58K | 155.95K | 159.53K | 658.37K | 843.79K |
| Accrued Expenses | 858.50K | 642.75K | 301.42K | 171.95K | 203.82K | 275.80K |
| Short-Term Debt | 700.00K | 700.00K | ||||
| Current Portion of Long-Term Debt | 37.20K | |||||
| Current Portion of Leases | 4.46K | 50.80K | 40.84K | |||
| Current Unearned Revenue | 386.80K | 130.00K | ||||
| Other Current Liabilities | 89.33K | 89.33K | 336.00K | 336.00K | ||
| Total Current Liabilities | 1.48M | 887.33K | 546.69K | 425.28K | 1.95M | 2.36M |
| Long-Term Debt | 22.92K | |||||
| Long-Term Leases | 4.46K | 49.09K | ||||
| Total Liabilities | 1.48M | 887.33K | 546.69K | 425.28K | 1.95M | 2.44M |
| Common Stock | 22.00K | 19.19K | 13.30K | 7.44K | 7.29K | 4.88K |
| Additional Paid-In Capital | 98.70M | 96.60M | 88.31M | 80.24M | 77.82M | 69.00M |
| Retained Earnings | -97.20M | -92.87M | -84.65M | -77.04M | -72.39M | -70.69M |
| Comprehensive Income & Other | 406.00 | -513.00 | -405.00 | 36.31K | ||
| Shareholders' Equity | 1.52M | 3.75M | 3.68M | 3.21M | 5.48M | -1.68M |
| Total Liabilities & Equity | 3.00M | 4.64M | 4.22M | 3.63M | 7.43M | 753.70K |
| Total Debt | 4.46K | 755.26K | 850.05K | |||
| Net Cash (Debt) | 1.00M | 3.72M | 3.48M | 2.94M | 6.24M | -188.27K |
| Net Cash Per Share | 1.56 | 6.81 | 11.33 | 12.00 | 33.59 | -1.33 |
| Filing Date Shares Outstanding | 734.55K | 686.05K | 443.45K | 247.88K | 242.88K | 163.50K |
| Total Common Shares Outstanding | 733.46K | 639.54K | 443.45K | 247.88K | 242.88K | 162.66K |
| Working Capital | 377.35K | 3.41M | 3.41M | 3.00M | 5.48M | -1.61M |
| Book Value Per Share | 2.07 | 5.86 | 8.29 | 12.94 | 22.56 | -10.34 |
| Tangible Book Value | 419.78K | 3.41M | 3.42M | 3.10M | 5.48M | -1.68M |
| Tangible Book Value Per Share | 0.57 | 5.33 | 7.70 | 12.51 | 22.56 | -10.34 |
| Machinery | 51.96K | 2.68K | 30.90K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -8.99M | -8.22M | -7.61M | -4.65M | -1.70M | -6.08M |
| Depreciation & Amortization | 45.53K | 21.54K | 15.11K | 4.25K | 535.00 | 537.00 |
| Loss (Gain) From Sale of Investments | -103.42K | -126.94K | -130.11K | -231.88K | ||
| Loss (Gain) on Equity Investments | 864.00 | 95.14K | ||||
| Stock-Based Compensation | 2.80M | 3.12M | 3.56M | 2.41M | 270.67K | 4.48M |
| Provision & Write-off of Bad Debts | 11.18K | |||||
| Other Operating Activities | 16.38K | 16.38K | 496.00 | -603.56K | -166.20K | |
| Change in Accounts Receivable | 6.91K | -68.53K | -3.67K | -4.49K | 253.00 | -9.70K |
| Change in Inventory | -76.87K | 26.73K | -18.16K | -7.81K | -142.85K | -8.75K |
| Change in Accounts Payable | -1.13K | 88.63K | -3.58K | -498.83K | -185.43K | 382.63K |
| Change in Unearned Revenue | -130.00K | 130.00K | ||||
| Change in Other Net Operating Assets | 171.25K | 182.59K | 147.07K | -257.72K | -176.04K | 28.47K |
| Operating Cash Flow | -6.13M | -4.96M | -3.94M | -3.84M | -2.22M | -1.08M |
| Capital Expenditures | -49.28K | |||||
| Sale (Purchase) of Intangibles | -130.59K | -96.86K | -170.31K | -109.28K | ||
| Investment in Securities | 5.46M | -35.13K | -407.23K | 4.56M | -6.79M | |
| Investing Cash Flow | 5.28M | -131.99K | -577.54K | 4.45M | -6.79M | |
| Short-Term Debt Issued | 200.00K | |||||
| Total Debt Issued | 200.00K | |||||
| Short-Term Debt Repaid | -200.00K | |||||
| Long-Term Debt Repaid | -37.20K | -9.60K | ||||
| Total Debt Repaid | -200.00K | -37.20K | -9.60K | |||
| Net Debt Issued (Repaid) | -200.00K | -37.20K | 190.40K | |||
| Issuance of Common Stock | 1.42M | 5.17M | 4.52M | 8.55M | 1.47M | |
| Financing Cash Flow | 1.42M | 5.17M | 4.52M | -200.00K | 8.51M | 1.66M |
| Miscellaneous Cash Flow Adjustments | -1.00 | |||||
| Net Cash Flow | 573.64K | 80.30K | -5.75K | 417.49K | -499.04K | 583.34K |
| Free Cash Flow | -6.18M | -4.96M | -3.94M | -3.84M | -2.22M | -1.08M |
| Free Cash Flow Margin | -2,845.05% | -1,643.53% | -2,337.82% | -3,463.16% | -167.68% | -747.43% |
| Free Cash Flow Per Share | -9.57 | -9.07 | -12.84 | -15.64 | -11.93 | -7.59 |
| Levered Free Cash Flow | -2.53M | -1.95M | -1.32M | -2.10M | -1.64M | 1.22M |
| Unlevered Free Cash Flow | -2.53M | -1.95M | -1.32M | -2.08M | -1.60M | 1.27M |
| Change in Working Capital | 100.17K | 229.42K | 121.65K | -768.86K | -634.07K | 522.64K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.24M | 10.41M | 35.50M | 3.01M | 5.45M | |
| Enterprise Value | 230.84K | 6.06M | 30.90M | -409.26K | -1.64M | |
| Last Close Price | 1.60 | 16.74 | 82.80 | 12.14 | 22.47 | |
| PS Ratio | 6.11 | 34.50 | 210.39 | 27.18 | 4.13 | |
| PB Ratio | 0.77 | 2.78 | 9.66 | 0.94 | 0.99 | |
| P/TBV Ratio | 3.16 | 3.05 | 10.39 | 0.97 | 0.99 | |
| EV/Sales Ratio | 1.48 | 20.07 | 183.17 | |||
| Debt / Equity Ratio | 0.00 | 0.14 | -0.51 | |||
| Net Debt / Equity Ratio | -0.66 | -0.99 | -0.95 | -0.92 | -1.14 | -0.11 |
| Net Debt / EBITDA Ratio | 0.11 | 0.45 | 0.45 | 0.52 | 3.40 | -0.03 |
| Net Debt / FCF Ratio | 0.16 | 0.75 | 0.88 | 0.77 | 2.82 | -0.17 |
| Asset Turnover | 0.04 | 0.07 | 0.04 | 0.02 | 0.32 | 0.33 |
| Inventory Turnover | 0.13 | 0.40 | 0.22 | 0.17 | 3.91 | 0.79 |
| Quick Ratio | 0.71 | 4.29 | 6.39 | 6.96 | 3.59 | 0.29 |
| Current Ratio | 1.25 | 4.84 | 7.25 | 8.06 | 3.81 | 0.32 |
| Return on Equity (ROE) | -240.25% | -221.50% | -221.05% | -107.05% | -89.44% | |
| Return on Assets (ROA) | -119.22% | -118.41% | -123.41% | -64.36% | -27.99% | -862.60% |
| Return on Capital Employed (ROCE) | -600.60% | -223.90% | -211.00% | -177.60% | -33.40% | 373.80% |
| Earnings Yield | -934.25% | -79.00% | -21.43% | -154.43% | -31.14% | |
| FCF Yield | -465.56% | -47.63% | -11.11% | -127.41% | -40.63% | |
| Buyback Yield / Dilution | -52.00% | -77.87% | -25.26% | -32.03% | -30.92% | -18.78% |